Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

The FDA said it would issue new guidelines for pulse oximeters by Sept. 30 to address inaccuracies in people with darker skin ...

Abortion is the ever-present health care issue in this race, and it offers a stark contrast between the two parties. But ...

Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...

Marrazzo became the first new director of the National Institute of Allergy and Infectious Diseases in decades, taking over a ...

Black Americans' higher exposures to pollutants could be fueling disparate cancer outcomes, according to a new study.

Metsera, a biotech focused on obesity treatments, came out of stealth only this year, and its lead drug is still in early ...

CVS Health is exploring options that could include a breakup of the company to separate its retail and insurance units ...

In an announcement shared exclusively with STAT, ambient documentation darling Abridge says it’s launching a new research ...

Micky Tripathi, the top AI official at HHS, faces down an enormous task with a dearth of people, resources, and enforcement ...

Sen. Bill Cassidy, seeking ways to help lower drug prices, is pushing the FDA to provide more clarity on patent listings in a ...

The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...